Does ESAB Corp’s (NYSE:ESAB) Current Price Make It Worth Investing In?
During the last session, ESAB Corp (NYSE:ESAB)’s traded shares were 0.89 million, with the beta value of the company hitting 1.27. At the end of
During the last session, ESAB Corp (NYSE:ESAB)’s traded shares were 0.89 million, with the beta value of the company hitting 1.27. At the end of
During the last session, Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares were 0.62 million, with the beta value of the company hitting 0.00. At the end
During the last session, Giftify Inc (NASDAQ:GIFT)’s traded shares were 0.58 million, with the beta value of the company hitting -1.54. At the end of
During the last session, Maxeon Solar Technologies Ltd (NASDAQ:MAXN)’s traded shares were 0.35 million, with the beta value of the company hitting 1.39. At the
During the last session, Fidelis Insurance Holdings Ltd (NYSE:FIHL)’s traded shares were 0.7 million, with the beta value of the company hitting 0.35. At the
During the last session, Dycom Industries, Inc (NYSE:DY)’s traded shares were 0.84 million, with the beta value of the company hitting 1.33. At the end
During the last session, LiveRamp Holdings Inc (NYSE:RAMP)’s traded shares were 0.77 million, with the beta value of the company hitting 1.03. At the end
During the last session, Imperial Oil Ltd (AMEX:IMO)’s traded shares were 0.77 million, with the beta value of the company hitting 0.89. At the end
During the last session, Axogen Inc (NASDAQ:AXGN)’s traded shares were 0.89 million, with the beta value of the company hitting 1.06. At the end of
During the last session, Macrogenics Inc (NASDAQ:MGNX)’s traded shares were 0.73 million, with the beta value of the company hitting 1.63. At the end of
© 2024, Powered by Smart TechOne